Navigation Links
TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
Date:8/19/2007

l trials, if any; whether pre-clinical results will be substantiated by ongoing or future clinical trials, if any, or whether any of its drug candidates will be able to improve the signs or symptoms of their respective clinical indication; whether any of its drug candidates will support an NDA filing, will be approved by the FDA or its equivalent, or if approved, will prove competitive in the market; or whether the necessary financing to support its drug development programs will be available. Actual results may differ materially from the above forward-looking statements due to a number of other important factors. These and other risks which may impact management's expectations are described in greater detail in the TorreyPines Therapeutics' annual report on Form 10-K for the year ended December 31, 2006 as well as TorreyPines Therapeutics' subsequent filings with the Securities and Exchange Commission. TorreyPines Therapeutics undertakes no obligation to publicly release the result of any revisions to such forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE TorreyPines Therapeutics, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. GTC Biotherapeutics to Webcast Corporate Presentation at the C.E. Unterberg, Towbin Emerging Growth Life Opportunities Conference
5. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
6. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
7. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
8. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
9. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
10. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
11. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2014)... , Sept. 14, 2014 /PRNewswire-iReach/ -- "Hematoma Global Clinical ... clinical trial scenario. This report provides elemental information and ... includes an overview of the trial numbers and their ... across the globe. The databook offers a preliminary coverage ... prominence of the sponsors and also provides briefing pertaining ...
(Date:9/14/2014)... , September 14, 2014 Elbit ... EMITF ) announced today further to the Company,s ... (the "Company,s Previous Reports"), that it was informed by ... US$ 12.5 million by  Shanghai GEOC Hengtong Investment Limited ... the framework of the present investment round in InSightec, ...
(Date:9/12/2014)... 2014 In the current outcomes-focused market, ... Health Outcomes Liaison (HOL) staff to serve as ... and other important healthcare decision makers. As the ... successful companies will need to understand how to ... To help organizations identify industry trends ...
Breaking Medicine Technology:Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014 2Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014 3Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014 4Hematoma Therapeutics Clinical Trials Market Overview on Companies, Top Institutes & Clinical Profiles to 2014 5Elbit Imaging Ltd. Announces Investment of US$ 12.5 Million in Insightec by Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Limited 2Elbit Imaging Ltd. Announces Investment of US$ 12.5 Million in Insightec by Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Limited 3Pharmaceutical Sector Turning to Health Outcomes Liaisons to Help Industry Navigate Payer-Focused Marketplace 2
(Date:9/14/2014)... 14, 2014 Adults who are planning ... Quotes Pros website to find quotes for life insurance ... year at http://quotespros.com/life-insurance.html is now delivering the ... partners that are preparing the rates information for adults ... most U.S. states. As a way to simplify the ...
(Date:9/14/2014)... York, New York (PRWEB) September 14, 2014 ... ) continue to move forward in courts throughout ... a brief filed in San Francisco Superior Court, ... have asked the judge overseeing the proceeding to ... their cases re-transferred to Los Angeles Superior Court. ...
(Date:9/14/2014)... Top10BestSEOHosting.com always offers truly reliable information ... suppliers carefully, the site has announced that Arvixe ... Best WordPress Hosting suppliers in the current market. ... web hosting provider, and the company’s reputation for ... provider known for its flexible hosting packages, decent ...
(Date:9/14/2014)... 14, 2014 School requires that children read ... that they be screened only for far vision when they ... away. When their eyes do not track effectively or ... will, at best, avoid reading; at worst, they will ... ability to learn. Children who cannot see cannot read. ...
(Date:9/13/2014)... PA (PRWEB) September 13, 2014 “I ... air we breathe, especially in major cities, is quite ... Ancaster, Ontario, Canada. “I thought we deserved a healthier ... they invented THE OXYGENIZER. , THE OXYGENIZER prevents pollutants ... and mouth. In doing so, it provides added peace ...
Breaking Medicine News(10 mins):Health News:Quotes for Life Insurance Now Offered at New Consumer Portal Online 2Health News:DePuy ASR Lawsuit News: Defense Asks Judge Overseeing California Litigation to Deny Opt-Out Plaintiffs’ Re-Transfer Request, Bernstein Liebhard LLP Reports 2Health News:DePuy ASR Lawsuit News: Defense Asks Judge Overseeing California Litigation to Deny Opt-Out Plaintiffs’ Re-Transfer Request, Bernstein Liebhard LLP Reports 3Health News:DePuy ASR Lawsuit News: Defense Asks Judge Overseeing California Litigation to Deny Opt-Out Plaintiffs’ Re-Transfer Request, Bernstein Liebhard LLP Reports 4Health News:Top10BestSEOHosting.com: The Best Linux Web Hosting Suppliers Now Unveiled 2Health News:Personal Air Filtering Device Invented by InventHelp Clients (TOR-9166) 2
... Nov. 11 Ken Herron, Chief Marketing,Executive at ... announced,today that David S. Novak of the Centers ... team at Online Buddies, Inc. as the site,s ... networking site for,gay men, with 2,000,000 members worldwide, ...
... - Global Health,innovator IntraHealth International will participate as ... to improve public health needs in the,West Bank, ... to Washington,DC-based Chemonics International and its subcontractors by ... The new Palestinian Health Sector Reform Project aims ...
... In women, habitual snoring may be an independent ... regardless of sleep apnea occurrences. Researchers from Sweden ... aged 20 to 70 years. The apnea-hypopnea index ... loudly and disturbingly often or very often were ...
... Germany, Nov. 11 Texas Instruments,(NYSE: ... of more than 15 dedicated,embedded processors which ... clinicians while empowering imaging equipment manufacturers to ... smaller and more portable.,These processors target several ...
... his speech today at electronica 2008, Pat O’Doherty, ... spotlighted how sophisticated healthcare semiconductor technology is paving ... and more powerful medical devices for use in ... of devices include those that check glucose levels ...
... 85 Americans die by suicide and hundreds of thousands more ... on suicide have focused on identifying psychiatric risk factors. However, ... published online this month in Social Science and Medicine ... closely analyzing the patterns of suicide in a single geographic ...
Cached Medicine News:Health News:MANHUNT Leads Fight Against Spread of Sexually Transmitted Infections with Launch of MANHUNT Cares; Hires Senior Public Health Strategist from CDC 2Health News:IntraHealth to Support Health Reform in Palestine 2Health News:Journal CHEST: Nov. highlights 2Health News:Video: Medical Imaging Equipment OEMs Can Achieve Faster, More Accurate Results with TI's Portfolio of Embedded Processors and Analog Products 2Health News:Video: Medical Imaging Equipment OEMs Can Achieve Faster, More Accurate Results with TI's Portfolio of Embedded Processors and Analog Products 3Health News:Video: Medical Imaging Equipment OEMs Can Achieve Faster, More Accurate Results with TI's Portfolio of Embedded Processors and Analog Products 4Health News:Video: Medical Imaging Equipment OEMs Can Achieve Faster, More Accurate Results with TI's Portfolio of Embedded Processors and Analog Products 5Health News: Analog Devices Healthcare Director Delivers Speech on Role of Analog Semiconductors in Next-Generation Portable Medical Equipment : ADI's Pat O'Doherty is a featured speaker at electronica 2008. 2Health News: Analog Devices Healthcare Director Delivers Speech on Role of Analog Semiconductors in Next-Generation Portable Medical Equipment : ADI's Pat O'Doherty is a featured speaker at electronica 2008. 3Health News:What happens in Vegas? Place as a risk factor for suicide 2
The Emit 2000 Digoxin Assay is a homogeneous enzyme immunoassay intended for use in the quantitative analysis of digoxin in human serum or plasma. Emit 2000 assays are designed for use with most chem...
Liquichek Rheumatoid Factor Control is a liquid trilevel control designed to monitor rheumatoid factor testing procedures, including nephelometric and latex agglutination methods....
... (Rapid Plasma Reagin) 18-mm Circle Card ... testing procedures for the serological detection ... of Tests for Syphilis.* The test ... most widely used in the United ...
... a non-reactive quality assurance reagent in assays detecting ... IgG and TOXO IgM), IgG and IgM antibodies ... IgG and IgM antibodies to cytomegalovirus (CMV IgG ... herpes simplex virus types 1 and 2 (HSV-1 ...
Medicine Products: